» Articles » PMID: 35757075

Varicella Pneumonia in an Immunocompetent, Unvaccinated Man: A Case Report

Overview
Journal IJID Reg
Date 2022 Jun 27
PMID 35757075
Authors
Affiliations
Soon will be listed here.
Abstract

Varicella is a common vaccine-preventable disease that typically affects children aged 2-8 years and usually has a benign outcome. However, varicella infection in adults may cause serious complications, including varicella pneumonia. We report a case of varicella pneumonia in an immunocompetent, unvaccinated man in Japan. A 50-year-old Egyptian man who had been living in Japan for 20 years was brought to the hospital with a 3-day history of fever and a 2-day history of rash and dyspnea. Chest computed tomography revealed an 8-mm-long nodule with a halo in the right S3 segment and mild ground-glass opacities in both lungs. A final diagnosis was made based on identification of varicella-zoster virus via positive immunochromatographic test and polymerase chain reaction from a blister fluid. The patient's pneumonia had improved with acyclovir for 10 days. In Japan routine varicella vaccination in childhood (at ages 12 and 18 months) was introduced in 2014. However, in Egypt, where the patient spent his childhood, varicella vaccine is still not designated as a routine vaccination. The introduction of universal varicella vaccination in more countries and an increase in vaccination coverage are essential to reduce the number of cases of varicella infection, including varicella pneumonia.

Citing Articles

Varicella pneumonia in an immunocompetent adult patient: Case report and review of the literature.

Arias-Osorio C, Lozada-Ramos H, Daza-Arana J, Osorio-Toro L, Bonilla-Bonilla D Respir Med Case Rep. 2024; 52:102112.

PMID: 39398873 PMC: 11466651. DOI: 10.1016/j.rmcr.2024.102112.

References
1.
Inoue N, Matsushita M, Fukui Y, Yamada S, Tsuda M, Higashi C . Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein. J Virol. 2012; 86(22):12198-207. PMC: 3486443. DOI: 10.1128/JVI.01280-12. View

2.
Baba K, Yabuuchi H, Takahashi M, Gershon A, Ogra P . Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine. J Pediatr. 1984; 105(5):712-6. DOI: 10.1016/s0022-3476(84)80288-7. View

3.
Mohsen A, McKendrick M . Varicella pneumonia in adults. Eur Respir J. 2003; 21(5):886-91. DOI: 10.1183/09031936.03.00103202. View

4.
Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B . Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004; 23(2):132-7. DOI: 10.1097/01.inf.0000109287.97518.67. View

5.
Takaya S, Kutsuna S, Katanami Y, Yamamoto K, Takeshita N, Hayakawa K . Varicella in Adult Foreigners at a Referral Hospital, Central Tokyo, Japan, 2012-2016. Emerg Infect Dis. 2019; 26(1):114-117. PMC: 6924900. DOI: 10.3201/eid2601.170565. View